AG
NTUS

Aperio Group’s Natus Medical Inc NTUS Stock Holding History

Aperio Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.38M Buy
68,810
+2,408
+4% +$47.2K ﹤0.01% 1417
2020
Q3 		$1.14M Buy
+66,402
New +$1.26M ﹤0.01% 1375
2020
Q2 		– Sell
-9,566
Closed -$221K – 2406
2020
Q1 		$221K Buy
+9,566
New +$278K ﹤0.01% 2058
2019
Q3 		– Sell
-4,654
Closed -$120K – 2900
2019
Q2 		$120K Buy
+4,654
New +$119K ﹤0.01% 2333
2019
Q1 		– Sell
-9,081
Closed -$309K – 2317
2018
Q4 		$309K Buy
9,081
+1,033
+13% +$33.6K ﹤0.01% 1925
2018
Q3 		$287K Sell
8,048
-883
-10% -$31.2K ﹤0.01% 2031
2018
Q2 		$308K Sell
8,931
-550
-6% -$19.3K ﹤0.01% 1987
2018
Q1 		$319K Buy
9,481
+2,890
+44% +$91.5K ﹤0.01% 1920
2017
Q4 		$252K Buy
6,591
+687
+12% +$27.4K ﹤0.01% 2040
2017
Q3 		$221K Sell
5,904
-679
-10% -$24K ﹤0.01% 2080
2017
Q2 		$246K Buy
6,583
+429
+7% +$15.5K ﹤0.01% 2009
2017
Q1 		$242K Sell
6,154
-717
-10% -$26.9K ﹤0.01% 1943
2016
Q4 		$239K Buy
6,871
+511
+8% +$20.1K ﹤0.01% 1904
2016
Q3 		$250K Buy
6,360
+662
+12% +$26.4K ﹤0.01% 1819
2016
Q2 		$215K Sell
5,698
-3,125
-35% -$105K ﹤0.01% 1830
2016
Q1 		$339K Buy
8,823
+2,398
+37% +$89.3K ﹤0.01% 1583
2015
Q4 		$309K Buy
6,425
+1,068
+20% +$49.4K ﹤0.01% 1601
2015
Q3 		$211K Buy
5,357
+145
+3% +$6.16K ﹤0.01% 1746
2015
Q2 		$222K Buy
5,212
+122
+2% +$4.86K ﹤0.01% 1802
2015
Q1 		$201K Buy
+5,090
New +$188K ﹤0.01% 1831

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aperio Group's NTUS Position: Q4 2020 in Review

Aperio Group increased its Natus Medical Inc (NTUS) stake by 3.6% in Q4 2020, buying an estimated $47.2K and bringing the position to 68,810 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Aperio Group first reported a position in NTUS in Q1 2015 and has held it in 20 quarters since. 163 funds tracked by Wall St. Rank hold NTUS as of Q4 2020.

  • Aperio Group held 68,810 shares of Natus Medical Inc worth $1.38M as of Q4 2020.
  • Aperio Group bought 2,408 Natus Medical Inc shares in Q4 2020, an estimated $47.2K.
  • Natus Medical Inc made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1417 holding.
  • Aperio Group first reported a position in Natus Medical Inc in Q1 2015 and has held it in 20 quarters since.
  • 163 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.